NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease

Levels of the Oxidative Stress Marker γ-Glutamyltranspeptidase at Different Stages of Nonalcoholic Fatty Liver Disease

(2013) M Irie et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Association Between Insulin Resistance and 
Oxidative Stress Parameters in Obese Adolescents with Non-Alcoholic Fatty Liver Disease

(2013) Pirgon Özgür et al.   Journal of Clinical Research in Pediatric Endocrinology

Review article: non-alcoholic fatty liver disease and osteoporosis - clinical and molecular crosstalk

(2012) Y. Yilmaz   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Urinary biomarkers of oxidative status

(2012) Dora Il'yasova et al.   CLINICA CHIMICA ACTA

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences

(2012) Maria Del Ben et al.   Internal and Emergency Medicine

Obesity and Hypercholesterolemia are Associated with NOX2 Generated Oxidative Stress and Arterial Dysfunction

(2012) Lorenzo Loffredo et al.   JOURNAL OF PEDIATRICS

Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment

(2012) Maria Del Ben et al.   BMC Pulmonary Medicine

Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome

(2011) Francesco Angelico et al.   Internal and Emergency Medicine

Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes

(2010) Sandhya Narasimhan et al.   CLINICAL BIOCHEMISTRY

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

(2010) Herbert Tilg et al.   HEPATOLOGY

Oxidative stress parameters in paediatric non-alcoholic fatty liver disease

(2010) Nobili   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

(2010) Giovanni Targher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atorvastatin Inhibits gp91 phox Circulating Levels in Patients With Hypercholesterolemia

(2009) Pasquale Pignatelli et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study

(2009) Ariel E. Feldstein et al.   HEPATOLOGY

Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study

(2009) Srinivasan Dasarathy et al.   JOURNAL OF HEPATOLOGY

Prostanoid and isoprostanoid pathways in atherogenesis

(2008) Domenico Praticò   ATHEROSCLEROSIS

High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women

(2008) Mark Roest et al.   Journal of Clinical Lipidology

Fatty Liver

(2007) Anna Kotronen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY